$78.45
Price
$46.1B
Market Cap
43.3
P/E Ratio
23.8
Forward P/E
$1.81
EPS (TTM)
—
Dividend Yield
$3.8B
Cash
$700M
Total Debt
580M
Shares Out
$65.94
$87.89
52-Week Range
Institutional Ownership of EDWARDS LIFESCIENCES
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for EDWARDS LIFESCIENCES
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2023-Q3 | |||||
| SELL | EXIT | — | — | $77.97 | |
| 2023-Q2 | |||||
| SELL | -4.5% | 315.2K | $30M | $87.41 | |
| 2023-Q1 | |||||
| SELL | -1.1% | 330.1K | $27M | $78.21 | |
| 2022-Q4 | |||||
| BUY | +0.6% | 333.8K | $25M | $75.03 | |
| 2022-Q3 | |||||
| BUY | NEW | 331.6K | $27M | $97.36 | |
| 2018-Q2 | |||||
| SELL | EXIT | — | — | $45.98 | |
| 2018-Q1 | |||||
| SELL | -15.5% | 1.1M | $158M | $43.94 | |
Insider Trading for EDWARDS LIFESCIENCES
6 Months Insider Sentiment
Buy $0
Sell $7.5M
0
Buys
16
Sells
-7.5M
Net
5
Grants
Largest
$1.8M
Zovighian
$1.5M
Zovighian
$951K
JR
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 09, 2026 | Daniel J. Lippis | CVP, TAVR | SELL | 1.0K | $85.70 | $87K |
| Jan 09, 2026 | Daniel J. Lippis | CVP, TAVR | EXERCISE | 1.0K | $59.26 | $60K |
| Jan 06, 2026 | Donald E Bobo JR | CVP,Strategy/Corp Development | SELL | 8.7K | $85.98 | $749K |
| Jan 06, 2026 | Donald E Bobo JR | CVP,Strategy/Corp Development | EXERCISE | 11.3K | $59.26 | $672K |
| Jan 06, 2026 | Donald E Bobo JR | CVP,Strategy/Corp Development | SELL | 2.6K | $84.62 | $223K |
| Dec 12, 2025 | Donald E Bobo JR | CVP,Strategy/Corp Development | SELL | 5.9K | $83.74 | $494K |
| Dec 12, 2025 | Daniel J. Lippis | CVP, JAPAC | EXERCISE | 1.0K | $59.26 | $60K |
| Dec 12, 2025 | Daniel J. Lippis | CVP, JAPAC | SELL | 1.0K | $84.03 | $86K |
| Dec 12, 2025 | Heisz Leslie Stone | Director | SELL | 2.6K | $83.41 | $218K |
| Dec 12, 2025 | Donald E Bobo JR | CVP,Strategy/Corp Development | GRANT | 7.1K | — | — |
| Dec 12, 2025 | Donald E Bobo JR | CVP,Strategy/Corp Development | SELL | 5.5K | $83.79 | $460K |
| Dec 11, 2025 | Daveen Chopra | CVP, TMTT & Surgical | SELL | 2.0K | $84.38 | $169K |
| Dec 10, 2025 | Donald E Bobo JR | CVP,Strategy/Corp Development | EXERCISE | 11.3K | $59.26 | $672K |
| Dec 10, 2025 | Donald E Bobo JR | CVP,Strategy/Corp Development | SELL | 11.3K | $83.83 | $951K |
| Dec 10, 2025 | Bernard J Zovighian | CEO | SELL | 3.9K | $83.45 | $322K |
| Dec 09, 2025 | Bernard J Zovighian | CEO | GRANT | 3.9K | — | — |
| Dec 09, 2025 | Scott B. Ullem | CVP, Chief Financial Officer | EXERCISE | 7.7K | $59.26 | $456K |
| Dec 09, 2025 | Scott B. Ullem | CVP, Chief Financial Officer | SELL | 7.7K | $84.47 | $650K |
| Dec 08, 2025 | Wayne Markowitz | CVP, JAPAC | SELL | 583 | $86.01 | $50K |
| Dec 08, 2025 | Bernard J Zovighian | CEO | EXERCISE | 25.4K | $59.26 | $1.5M |
| Dec 08, 2025 | Bernard J Zovighian | CEO | SELL | 21.5K | $85.21 | $1.8M |
| Nov 13, 2025 | Andrew M. Dahl | SVP, Corporate Controller | GRANT | 1.2K | — | — |
| Nov 10, 2025 | Scott B. Ullem | CVP, Chief Financial Officer | EXERCISE | 13.0K | $59.26 | $770K |
| Nov 10, 2025 | Scott B. Ullem | CVP, Chief Financial Officer | SELL | 3.0K | $83.30 | $248K |
| Nov 10, 2025 | Scott B. Ullem | CVP, Chief Financial Officer | SELL | 10.0K | $83.02 | $832K |
| Nov 10, 2025 | Daniel J. Lippis | CVP, JAPAC | EXERCISE | 1.0K | $59.26 | $60K |
| Nov 10, 2025 | Daniel J. Lippis | CVP, JAPAC | SELL | 1.0K | $82.55 | $84K |
| Sep 11, 2025 | Wayne Markowitz | CVP, JAPAC | GRANT | 6.4K | — | — |
| Sep 11, 2025 | Daveen Chopra | CVP, TMTT & Surgical | GRANT | 3.2K | — | — |